FDA Investigator Yvette I Henry

Yvette I Henry has conducted inspections on 8 sites in 4 countries as of 18 Nov 2002. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
8
Last Inspection Date:
18 Nov 2002
Investigator Role:
FDA Investigation Participant
Redica ID:
100004752
Countries of Inspections:
China, Switzerland, Korea (Republic of), United States of America
FDA Investigators that have inspected at least one site in common with Yvette I Henry:
Anita R Michael, Anthony A Charity, Arsen Karapetyan, Brandy N Lepage, CDR Ileana Barreto Pettit, Charles M Edwards, Christina K Theodorou, Debra L Pagano, Douglas C Kovacs, Dr. Mark J Seaton, PhD, Edwin Martinez, Farhana Khan, Guerlain Ulysse, Gwyn G Dickinson, Herbert M Corbello, James C Maclaughlin, Joanne Hajoway, Joanne M Hajoway, José E Meléndez, Jose R Hernandez, Kent C Faul, Kham Phommachanh, Kristina J Donohue, Larry K Austin, LCDR Chad N Thompson, Maria A Reed, Mary E Storch, Meredith P Soehl, Investigator, Michael D Omeara, Michele M Falchek, Nicole E Knowlton, Parul M Patel, Paul L Bellamy, Peter E Baker, Prabhu P Raju, Rachael A Moliver, Richard H Penta, Rochelle L Cross, Sarah E Mcmullen, Sony Mathews, Susan W Ting, Tammy L Chavis, Tiffani D Wilson, Vlada Matusovsky, Yvette I Johnson, Zi Qiang Gu

Yvette I Henry's Documents

Publish Date Document Type Title
May, 2000 EIR SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. - EIR, 2000-05-10
November, 2002 EIR Charles River Laboratories, Inc. - EIR, 2002-11-25
September, 2001 EIR Chongqing Daxin Pharmaceutical Co., Ltd. - EIR, 2005-05-26
November, 2002 FDA 483 Response Charles River Laboratories, Inc. - Form 483R, 2002-12-19
September, 2001 FDA 483 Chongqing Daxin Pharmaceutical Co., Ltd. - Form 483, 2001-09-25
November, 2002 FDA 483 Charles River Laboratories, Inc. - Form 483, 2002-11-25
May, 2000 EIR Pucheng Chia Tai Biochemistry Co., Ltd. - EIR, 2000-05-17
September, 2001 EIR Zhejiang Shenghua Biok Biology Co., Ltd. - EIR, 2001-09-19
September, 2001 FDA 483 Zhejiang Shenghua Biok Biology Co., Ltd. - Form 483, 2001-09-19
August, 2002 FDA 483 Response DSM Nutritional Products AG Zweigniederlassung Werk Sisseln - Form 483R, 2002-09-02
May, 2000 FDA 483 Pucheng Chia Tai Biochemistry Co., Ltd. - Form 483, 2000-05-17
August, 2002 FDA 483 Roche AG - Form 483, 2002-08-23
May, 2000 FDA 483 Response Kprea Otsuka Pharmaceutical Co. - Form 483R, 2000-08-24
August, 2002 EIR DSM Nutritional Products AG Zweigniederlassung Werk Sisseln - EIR, 2002-10-07
May, 2000 EIR Kprea Otsuka Pharmaceutical Co. - EIR, 2000-05-05

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more